ObjectivesCigarette smoking is the leading preventable cause of death and disability. Although most US smokers want to quit, more than 95% of cessation attempts end in relapse within 6 months. To improve cessation outcomes, research has turned to targetable mechanisms, such as anxiety sensitivity (AS), which maintain smoking behaviour, impede cessation success, and can be effectively targeted in the context of psychosocial interventions. Although integrated treatment programmes that address AS reduction in the context of smoking cessation have demonstrated promising results, presently, no mobile, technology‐based integrated treatment exists to expressly address smoking and AS. The current study evaluated the initial feasibility and acceptability of a mobile smoking cessation intervention, Mobile Anxiety Sensitivity Program for smoking (MASP).MethodsParticipants were 15 daily adult combustible cigarette smokers (females n = 6, Mage = 46.5 years, SD = 13.3) who completed a 6‐week total intervention period (baseline visit, 2 weeks pre‐quit, 4 weeks post‐quit, follow‐up visit).ResultsMost participants (N = 12) completed the full 6‐week intervention, and participant engagement with MASP was high. Participants reported that MASP was acceptable. Biochemical verification of smoking abstinence indicated 25% of smokers were abstinent for at least 24 hr prior to the in‐person 4 weeks post‐quit follow‐up visit.ConclusionsFindings indicated that MASP has the potential to provide effective assistance to those wanting to quit cigarettes.Practitioner points Mobile‐based smoking cessation interventions may be a promising treatment option, particularly for those of lower socio‐economic status. Targeting AS in the context of a mobile‐based smoking cessation app may be a viable way to improve smoking cessation success and treatment outcome. Due to the pilot nature of this study, there was no control group. Thus, comparative conclusions and generalizability based on the current study must be made with caution.

No abstract

No abstract

Recent years have been marked by an increase in electronic cigarette (e-cigarette) use. Although some evidence suggests that e-cigarettes used in isolation may be less harmful than combustible cigarettes, e-cigarette use carries significant health risks. Data are critically needed to identify risk factors that promote and maintain e-cigarette use. The current project examined how the relation between pain interference (i.e., how much pain interferes with daily functioning) and cognitive processes of e-cigarette use (i.e., perceived barriers for quitting e-cigarettes, perceived risks of e-cigarettes, and negative expectancies of using e-cigarettes) differ across sex. Participants included 340 (61.5% female; 77.1% Caucasian/White; Mage = 36.68 years, SD = 10.75) adult past-month e-cigarette users. Results suggested that increased pain interference was more strongly related to greater perceived barriers to cessation, perceived risks of e-cigarettes, and negative expectancies of using e-cigarettes among males relative to females. Importantly, this work suggests that e-cigarette use may operate differently than other substances that have been studied in the past in that male e-cigarette users may be more vulnerable than female e-cigarette users to the effects of pain interference on cognitive processes of e-cigarette use.

No abstract